Document is current
Any future updates will be listed below
-
Authors
Shanmugam, Ashwini https://orcid.org/0000-0002-4999-2528
Merrigan, Michael
O’Reilly, Seamus
Molloy, Anne M.
Brody, Lawrence https://orcid.org/0000-0001-9435-3592
Hardiman, Orla
Bodmer, Walter
McLaughlin, Russell L. https://orcid.org/0000-0003-3915-2135
Cavalleri, Gianpiero L. https://orcid.org/0000-0002-9802-0506
Byrne, Ross P. https://orcid.org/0000-0002-4082-6072
Gilbert, Edmund H. https://orcid.org/0000-0002-5574-4520
-
Funding
Funding for this research was provided by:
Science Foundation Ireland (18/CRT/6214, 6/RC/3948, 17/CDA/4737, 15/SPP/3244, 6/RC/3948, 18/CRT/6214, 6/RC/3948, 17/CDA/4737, 15/SPP/3244, 6/RC/3948)
Motor Neurone Disease Association (879-791, 979-799, 879-791, 979-799)
- License Information
-
More Information
Article History
Received: 29 May 2024
Revised: 10 November 2024
Accepted: 17 January 2025
First Online: 5 February 2025
Competing interests
: O.H. has received speaking honoraria from Janssen Cilag, Biogen, Sanofi Aventis, Novartis, Merck-Serono and Cytokenetics. She has been a member of advisory panels for Biogen, Novartis, Cytokenetics, Denali and Neurosense. She serves as Editor-in-Chief of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
: Please refer to the published articles for details; Trinity Student Study dataset [], the Peoples of the British Isles dataset [], and the WTCCC2 Multiple Sclerosis dataset [].
